Transition piece, 45/40, 29/32, 1 Piece

3-Methoxypyridine-2-carbaldehyde, 95.0%, 10g

Tert-butyl n-(5-formylpyrazin-2-yl)carbamate, 97%, 100mg

18-Bromo-2,3,5,6,8,9,11,12,14,15-decahydrobenzo[b][1,4,7,10,13,16]Hexaoxacyclotetradecene, 97%, 250mg

2-Chloro-4-fluorocinnamic acid, 95.0%, 25g

5-BROMO-2-FLUORO-4-METHYLBENZOIC ACID, 95.0%, 5g

Methyl thieno[2,3-b]pyridine-2-carboxylate, 97%, 5g

GC capillary column ROTI®Cap-1 MS, 30 m, 0.25 mm, 0.25 µm, 1 Piece(s)

(2-Bromo-4-nitrophenyl)methanol, 95+%, 5g

ISOPROPYL ((R)-(((2R,3R,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-4-FLUORO-3-HYDROXY-4-METHYLTETRAHYDROFURAN-2-YL)METHOXY)(PHENOXY)PHOSPHORYL)-D-ALANINATE, 95%, 1mg

tert-Butyl Thiazol-2-ylcarbamate, 97.0%, 10g

4-Bromo-2-fluoro-5-nitrobenzoic acid, 95+%, 100mg

5,6-Dihydrobenzo[d]thiazol-7(4H)-one, 95.0%, 10g